Spots Global Cancer Trial Database for stage ii childhood lymphoblastic lymphoma
Every month we try and update this database with for stage ii childhood lymphoblastic lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia | NCT00324779 | Leukemia Lymphoma | rituximab | - 18 Years | National Cancer Institute (NCI) | |
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | NCT00275106 | Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisolone thioguanine vincristine sul... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | NCT00290641 | Chronic Myelopr... Leukemia Lymphoma Myelodysplastic... | filgrastim graft-versus-tu... cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... umbilical cord ... radiation thera... | - 45 Years | Masonic Cancer Center, University of Minnesota | |
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | NCT00018954 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... doxorubicin hyd... etoposide ifosfamide mercaptopurine methotrexate prednisone vincristine sul... conventional su... radiation thera... | - | National Institutes of Health Clinical Center (CC) | |
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | NCT00003728 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisolone therapeutic hyd... thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... | - 17 Years | National Cancer Institute (NCI) | |
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | NCT00003423 | Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide mercaptopurine methotrexate prednisolone thioguanine vincristine sul... | - 14 Years | National Cancer Institute (NCI) | |
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | NCT00004898 | Leukemia Lymphoma | filgrastim cyclophosphamid... etoposide peripheral bloo... radiation thera... | - 65 Years | Northwestern University |